Our People
Team Members
Lead
Peter Zandstra
Co-applicants
Anna Blakney, Annie Ciernia, Pieter Cullis, Pauline Johnson, Hongshen Ma, Kelly McNagny, Alice Mui, Maria Tokuyama, Carolina Tropini, Nozomu Yachie
Faculty Collaborators
Yossef Av-Gay, Horacio Bach, Phillip Domeier, Laura Evgin, Ken Harder, Yanpu He, Govind Kaigala, Lisa Osborne, Morgan Roberts, Nika Shakiba, Laura Sly, Jim Sun, Simon Wisnovsky
Photos coming soon below!
NAME
NAME
NAME
NAME
NAME
NAME
NAME
NAME
NAME
NAME
NAME
NAME
NAME
NAME
NAME
NAME
NAME
NAME
NAME
NAME
Industry Partners
NAME
NAME
NAME
NAME
NAME
NAME
NAME
NAME
NAME
NAME
ImmunoE Trainees
2027 cohort
Amir Golzan
Program: PhD, Experimental Medicine
Exploring the Therapeutic Potential of GlycoCaged Thiopurine in IBD
Anjali Parthasarathy
Program: MSc, Pharmaceutical Sciences
Functional Mapping of the Human T-cell Glycome Using Base Editing Screens
Armin Faghihi Taleghani
Program: MSc, Biochemistry and Molecular Biology
Designing Lipid Nanoparticle-Based Tools to Engineer Macrophages In Vivo for Solid Tumor Immunotherapy
Asana Imanpour
Program: PhD, Interdisciplinary Oncology
Tumour-Immune Interactions in Resistance to Neoadjuvant Therapies in Muscle-Invasive Bladder Cancer
Catherine Ko
Program: MSc, Biomedical Engineering
Developing a smart bioprocess control system that monitors and adjusts iPSC differentiation toward hematopoietic stem and progenitor cells in real-time
Daniella Liao
Program: MSc, Interdisciplinary Oncology
Exploring B-cell Responses in Lung Cancer
Juliana Montoya Sanchez
Program: PhD, Biochemistry and Molecular Biology
New RNA delivery techniques for examining microglial histone lactylation in vitro
Kisa Naqvi
Program: MSc, Experimental Medicine
Engineering chimeric antigen receptor regulatory T cell (CAR Treg) therapy to prevent allograft rejection and induce immune tolerance
Natalie Chong
Program: MSc, Microbiology and Immunology
Novel drug against multidrug-resistant Mycobacterium tuberculosis
Maya Nathani-Sim
Program: MASc, Biomedical Engineering
Engineering bispecific natural killer cells to target cancer metabolic heterogeneity
Natalia Nayyar
Program: MSc, Experimental Medicine
Targeting podocalyxin for the treatment adverse-risk acute myeloid leukemia
Pegah Karimi
Program: PhD, Microbiology and Immunology
mRNA cancer Vaccines
Qing Ru Kong
Program: MSc, Experimental Medicine
Cell-based immunoengineering approach using engineered regulatory T cells as a therapy for ARDS
Sogand Golshahian
Program: MASc, Biomedical Engineering
Analysis of gene and protein expression data in patient cohorts with neurodegenerative and infectious diseases
Tithi Bhatt
Program: MSc, Microbiology and Immunology
Exploring B cell Selection in Germinal Centers Using Tonsil Organoids
Wanda Janaeska
Program: PhD, Biomedical Engineering
Next-generation cancer vaccines using self-amplifying RNA (saRNA)
2026 cohort
Sunny Chen
Program: PhD, Biomedical Engineering
Exploring the Therapeutic Potential of GlycoCaged Thiopurine in IBD
Cynthia Huang
Program: MASc, Biomedical Engineering
Functional Mapping of the Human T-cell Glycome Using Base Editing Screens
Kaye Soriano
Program: PhD, Biomedical Engineering
Designing Lipid Nanoparticle-Based Tools to Engineer Macrophages In Vivo for Solid Tumor Immunotherapy
Ceren Gulhan
Program: MSc, Interdisciplinary Oncology
Tumour-Immune Interactions in Resistance to Neoadjuvant Therapies in Muscle-Invasive Bladder Cancer
Ali Koshyk
Program: MSc, Microbiology and Immunology
Developing a smart bioprocess control system that monitors and adjusts iPSC differentiation toward hematopoietic stem and progenitor cells in real-time
Megha Srinivas
Program: PhD, Biomedical Engineering
Exploring B-cell Responses in Lung Cancer
Katia Rosenflanz
Program: MSc, Biomedical Engineering
New RNA delivery techniques for examining microglial histone lactylation in vitro
Tae Kim
Program: PhD, Biomedical Engineering
Engineering chimeric antigen receptor regulatory T cell (CAR Treg) therapy to prevent allograft rejection and induce immune tolerance
Grace Kuo
Program: PhD, Experimental Medicine
Novel drug against multidrug-resistant Mycobacterium tuberculosis
Jeff Yoon
Program: PhD, Biochemistry and Molecular Biology
Engineering bispecific natural killer cells to target cancer metabolic heterogeneity
Parisa Nazari
Program: MSc, Biomedical Engineering
Targeting podocalyxin for the treatment adverse-risk acute myeloid leukemia
Lucas Zhu
Program: MSc, Microbiology and Immunology
mRNA cancer Vaccines
Maggie Ma
Program: PhD, Experimental Medicine
Cell-based immunoengineering approach using engineered regulatory T cells as a therapy for ARDS
Lily Bertolo
Program: MSc, Microbiology and Immunology
Analysis of gene and protein expression data in patient cohorts with neurodegenerative and infectious diseases
Imogen Porter
Program: PhD, Genome Science and Technology (GSAT)
Exploring B cell Selection in Germinal Centers Using Tonsil Organoids
Claire Sie
Program: PhD, Microbiology and Immunology
Next-generation cancer vaccines using self-amplifying RNA (saRNA)
Sam Khalilitousi
Program: MASc, Biomedical Engineering
Next-generation cancer vaccines using self-amplifying RNA (saRNA)
Committees
Program AdvisoryCommittee
NAME
NAME
NAME
NAME
NAME
NAME
NAME
NAME
NAME
NAME
ImmunoT&E Trainee Committee
NAME
NAME
NAME
NAME
NAME
NAME
NAME
NAME
NAME
NAME
© Copyright 2025 by ImmunoT & ImmunoE